 high prevalence antibody hepatitis virus patients hepatocellular carcinoma Japan Japan hepatocellular carcinoma HCC prevalent cancers fatality rate consistent significant increase last decade HCC cases positive hepatitis surface antigen HBsAg potential role hepatitis virus HCV development HCC sera HBsAg-negative HCC patients districts Japan antibody HCV antigen HCVAb large number patients positive HCVAb comparison prevalence sera blood donors history blood transfusion cases positive HCVAb different rate HCC patients positive HBsAg negative HCVAb